Magic mushrooms reduces anxiety and depression in cancer patients

Information is out of date

A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer, according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.  psilocybe azurescens dried

Patients who receive a cancer diagnosis develop debilitating symptoms of anxiety and depression. Reports from the 1960s and 1970s suggest that hallucinogenic drugs such as LSD may alleviate such symptoms in cancer patients. Still, the clinical value of hallucinogenic drugs for treating mood disturbances in cancer patients remains unclear. Psilocybe Azurescens Dried For Sale

In this new study, Roland Griffiths and colleagues from the Johns Hopkins University School of Medicine investigated the effects of psilocybin on symptoms of anxiety and depression in individuals diagnosed with life-threatening cancer. dried psilocybe azurescens

Five weeks after receiving a dose of psilocybin sufficiently high to induce changes in perception and mystical-type experiences, patients reported significantly lower levels of anxiety and depression compared with patients that received a low dose of the drug. The positive effects on mood persisted in the patients at six month follow-up. Buy psychedelics online

The authors suggest that a single dose of psilocybin may be sufficient to produce enduring decreases in negative mood in patients with life-threatening cancer. Psychedelics for sale

https://pychedelichigh.com